Official Government Website

Idaho PMP

Idaho Prescription Monitoring Program (AWARxE)

Effective July 1, 2017: Idaho Code 37-2726

(3) The board shall require pharmacists and prescribers, except veterinarians, to annually register with the board to obtain online access to the controlled substances prescriptions database.

Register for the PDMP here: https://idaho.pmpaware.net

Request Statistical Data here


Prescribers and Pharmacists:


Idaho PMP AWARxE User Support Guide & Registration Instructions

Idaho PMP AWARxE Data Submission Guide

FAQ


The prescription monitoring program is a statewide electronic database which collects designated data on controlled substances dispensed in the state of Idaho.

In an effort to assist prescribers and pharmacists with patient care related to controlled substance prescriptions and to combat prescription drug abuse, the Idaho Prescription Monitoring Program was implemented in 1997 (under title 37, chapter 27, 37-2726 (2)). It is a tool provided to prescribers of controlled substances and to pharmacists who are considering dispensing controlled substance prescriptions to patients.

IDAPA 27.01.03.600 states, “Specified data on controlled substances must be reported by the end of the next business day by all drug outlets that dispense controlled substances in or into Idaho and prescribers that dispense controlled substances to humans. Data on controlled substance prescription drug samples does not need to be reported.”

The overview provided by National Alliance for Model State Drug Laws (NAMSDL) clearly identifies the benefits of a PDMP: as a tool used by states to address prescription drug abuse, addiction and diversion, it may serve several purposes such as:

    1. support access to legitimate medical use of controlled substances,
    2. identify and deter or prevent drug abuse and diversion,
    3. facilitate and encourage the identification, intervention with and treatment of persons addicted to prescription drugs,
    4. inform public health initiatives through outlining of use and abuse trends, and
    5. educate individuals about PDMPs and the use, abuse and diversion of and addiction to prescription drugs.

(https://www.deadiversion.usdoj.gov/faq/rx_monitor.htm

Idaho Code 37-2726

(9) Any person with access to the board’s online prescription monitoring program pursuant to a board-issued user account, login name and password who intentionally shares or recklessly fails to safeguard his user account, login name and password, resulting in another person not authorized to receive or use such information under the provisions of any state or federal law, rule or regulation obtaining information from the controlled substances prescriptions database, shall be guilty of a misdemeanor, punishable by imprisonment in a county jail not to exceed six (6) months or by a fine not to exceed two thousand dollars ($2,000), or both. The foregoing criminal penalty is in addition to, and not in lieu of, any other civil or administrative penalty or sanction authorized by law.

Board Rule 204.02 Use Outside Scope of Practice Prohibited

Information obtained from the PMP must not be used for purposes outside the prescriber’s or pharmacist’s scope of professional practice.

Idaho Code 37-2726(2)

  1. Authorized individuals employed by Idaho’s boards or other states’ licensing entities charged with the licensing and discipline of practitioners;
  2. Peace officers employed by federal, state and local law enforcement agencies engaged as a specified duty of their employment in enforcing law regulating controlled substances;
  3. Authorized individuals under the direction of the department of health and welfare for the purpose of monitoring and enforcing that department’s responsibilities under the public health, medicare and medicaid laws;
  4. A practitioner, licensed in Idaho or another state, having authority to prescribe controlled substances, or a delegate under the practitioner’s supervision, to the extent the information relates specifically to a current patient of the practitioner to whom the practitioner is prescribing or considering prescribing any controlled substance;
  5. A pharmacist, licensed in Idaho or another state, having authority to dispense controlled substances, or a delegate under the pharmacist’s supervision, to the extent the information relates specifically to a current patient to whom that pharmacist is dispensing or considering dispensing any controlled substance, or providing pharmaceutical care as defined in the Idaho pharmacy act;
  6. An individual who is the recipient of a dispensed controlled substance entered into the database may access records that pertain to that individual, upon the production of positive identification, or that individual’s designee upon production of a notarized release of information by that individual;
  7. Upon a lawful order issued by the presiding judge in a court of competent jurisdiction for the release of prescription monitoring program records of a named individual;
  8. Prosecuting attorneys, deputy prosecuting attorneys and special prosecutors of a county or city and special assistant attorneys general from the office of the attorney general engaged in enforcing law regulating controlled substances; and
  9. A medical examiner or coroner who is an officer of or employed by a state or local government, for determining a cause of death or for performing other duties authorized by law.

Prescribers and pharmacy staff are instructed to:

  • Report forgeries, altered scripts and phony called in prescription to the prescriber, law enforcement and the Board office.
  • Report ‘doctor shoppers’ to the Board office, who will then work with the appropriate law enforcement agency
  • Report excessive prescribing to Board office, who will then work with the appropriate licensing board

The ultimate goal is for patients to receive the treatment they need. Practitioners are encouraged to assist patients in finding substance abuse treatment programs in their area. More information about substance abuse prevention and treatment can be found at the Department of Health & Welfare’s website.

IDAPA 27.01.01.600.02 Use Outside Scope of Practice Prohibited

Information obtained from the PMP must not be used for purposes outside the prescriber’s or pharmacist’s scope of professional practice.

Examples of misuse include:

  • Pharmacist searching PMP records for family or extended family members’ prescription history.
  • Prescriber’s employee searching for boyfriend, girlfriend, ex-spouse prescription history.
  • Parent searching adult child’s prescription history.
  • Employer searching employee or potential employee prescription records
Idaho Code 37-2726

(9) Any person with access to the board’s online prescription monitoring program pursuant to a board-issued user account, login name and password who intentionally shares or recklessly fails to safeguard his user account, login name and password, resulting in another person not authorized to receive or use such information under the provisions of any state or federal law, rule or regulation obtaining information from the controlled substances prescriptions database, shall be guilty of a misdemeanor, punishable by imprisonment in a county jail not to exceed six (6) months or by a fine not to exceed two thousand dollars ($2,000), or both. The foregoing criminal penalty is in addition to, and not in lieu of, any other civil or administrative penalty or sanction authorized by law.

Information obtained from the PMP must not be used for purposes outside the prescriber’s or pharmacist’s scope of professional practice.

Idaho Code 37-2730A (2) The board shall use the information obtained through the tracking program in identifying activity it reasonably suspects may be in violation of this chapter or medical assistance law. The board shall report this information to the individuals and persons set forth in section 37-2726(2), Idaho Code. The board may release unsolicited information to pharmacists and practitioners when the release of information may be of assistance in preventing or avoiding inappropriate use of controlled substances. The board may provide the appropriate law enforcement agency, medicaid, or medicare agency or licensing board with the relevant information in the board’s possession, including information obtained from the tracking program, for further investigation, or other appropriate law enforcement or administrative enforcement.
Reports are automatically generated and sent to practitioners when threshold numbers of prescribers and pharmacies have been reached or exceeded by a patient during a given month. Some benefits to receiving these reports include:

  1. Accurate background information on new patients.
  2. Current patients can be monitored.
  3. Reports provide warnings on patients who may be misusing or diverting controlled substance prescription drugs and can assist prescribers in coordination of care.

The Board encourages prescribers to review any Unsolicited Reports they receive to confirm whether or not they wrote or authorized the prescriptions shown on the reports. If the report is accurate, prescribers are advised to discuss their concerns with the patient. If one or more entries on the report appear to be inaccurate, prescribers are asked to contact the Board office. Staff will investigate any discrepancies and notify the prescriber of the outcome. Prescribers may also want to keep a copy of the report in the patient’s chart for future reference.


Additional Information

NarxCare – Product Information
PMP Gateway – Product Information


Questions?

For more information on Diversion or the Prescription Monitoring Program see our Contact Us to inquire

ver: 3.3.0 | last updated: